@article{article_945846, title={Kaposi’s sarcoma in an Ankylosing Spondylitis patient treated with Anti-Tumor Necrosis Factor-Alpha (Anti-TNF-α) Therapy}, journal={Turkish Journal of Internal Medicine}, volume={4}, pages={49–53}, year={2022}, DOI={10.46310/tjim.945846}, author={Hakbilen, Selda and Tezcan, Dilek and Yilmaz, Sema}, keywords={Tumor necrosis factor-alpha inhibitors, Kaposi, ankylosing spondylitis}, abstract={Tumor necrosis factor-alpha (TNF-α) inhibitors are immunosuppressive agents used in a variety of inflammatory diseases, including rheumatoid arthritis (RA), spondyloarthritis, psoriasis, and inflammatory bowel disease (IBD). Kaposi’s sarcoma (KS) is an angioproliferative disease associated with the human herpes virus 8 (HHV-8). We present a 46-year-old male patient with ankylosing spondylitis (AS) treated with TNF-α inhibitor and developed KS during follow-up. The coexistence of anti-TNF-α treatment with KS is a rare condition. This case is presented to address this rare association. Therefore, keeping in mind KS, which is a type of skin tumor, in such HIV-negative patients in whom immunosuppressive agents are initiated, is essential in terms of early diagnosis, treatment, and prevention of complications.}, number={1}, publisher={Nizameddin KOCA}, organization={yok}